2020-06-24
Positive results from Phase 2 study
Positive results from Phase 2 study of once-weekly FluidCrystal® formulation of setmelanotide in healthy volunteers with obesity.
Read more: https://www.camurus.com
2020-06-24
Positive results from Phase 2 study of once-weekly FluidCrystal® formulation of setmelanotide in healthy volunteers with obesity.
Read more: https://www.camurus.com
2021-11-03
Martin Jonsson´s successor as President and CEO of the Sandberg Development Group has now been appointed and it is w…
Read more2021-07-15
Today, Camurus' interim report for the second quarter 2021 was published. "It was a positive second quarter with sig…
Read more2021-05-20
Camurus has been awarded with the Carnegie Sustainability Award 2021 in the category small-cap, presented at the Car…
Read more2021-04-21
Camurus Annual Report for 2020 is now available at the company's website.
Read more2021-02-19
Granuldisk was selected as one of the finalists presented by Malmö Näringslivsgala, a business gala for companies lo…
Read more